Elanco shareholders approve ESPP, eliminate supermajority voting; director elected despite majority against

Elanco Animal Health Inc

Shareholders approved elimination of supermajority vote to remove directors, replaced with majority vote.
Approved Employee Stock Purchase Plan reserving 625,000 shares for employees.
Charter amendments to remove legacy parent provisions passed with 99.98% votes in favor.
Director Kapila Kapur Anand elected despite 50.1% against votes; other nominees received >86% support.
All six proposals passed at May 18, 2022 annual meeting; Ernst & Young ratified as auditor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.